Hensley Mark Earl (CIK 2065816) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy HRTX (31,250 shares), Sell HRTX (8,888 shares), Buy HRTX (11,769 shares), Buy HRTX (125,000 shares), Buy HRTX (11,770 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Buy | 31,250 | $0 |
| 2026-08-10 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Sell | 8,888 | $4,444 |
| 2026-08-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Buy | 11,769 | $0 |
| 2026-05-07 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Buy | 125,000 | $0 |
| 2026-05-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Buy | 11,770 | $0 |
Source: SEC Form 4 filings · as of 2026-08-10